Cyclin-dependent kinase 5 activity is required for T cell activation and induction of experimental autoimmune encephalomyelitis

Journal of Experimental Medicine

Volumn 207, Issue 11, 2010, Pages 2507-2519

  Pareek, Tej K ^a   Lam, Eric ^a   Zheng, Xiaojing ^a   Askew, David ^a   Kulkarni, Ashok B ^b   Chance, Mark R ^a   Huang, Alex Y ^a   Cooke, Kenneth R ^a   Letterio, John J ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; CORONIN 1A; CYCLIN DEPENDENT KINASE 5; MACROPHAGE INFLAMMATORY PROTEIN 3BETA; PROTEIN P35; REGULATOR PROTEIN; T LYMPHOCYTE RECEPTOR; THREONINE; UNCLASSIFIED DRUG;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CELL MIGRATION; COMPLEX FORMATION; ENZYME ACTIVITY; GENE EXPRESSION; HEMATOPOIETIC TISSUE; MOUSE; NONHUMAN; POLARIZATION; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION;

ANIMALS; CELL MOVEMENT; CYCLIN-DEPENDENT KINASE 5; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HEMATOPOIETIC STEM CELL TRANSPLANTATION; LYMPHOCYTE ACTIVATION; MICE; MICE, KNOCKOUT; MICROFILAMENT PROTEINS; MULTIPLE SCLEROSIS; MULTIPROTEIN COMPLEXES; RECEPTORS, ANTIGEN, T-CELL; T-LYMPHOCYTES; TRANSPLANTATION CHIMERA; TRANSPLANTATION, HOMOLOGOUS;

EID: 78149352604     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.20100876     Document Type: Article

References (60)

1. Alt, C., M. Laschinger, and B. Engelhardt. 2002. Functional expression of the lymphoid chemokines CCL19 (ELC) and CCL 21 (SLC) at the blood-brain barrier suggests their involvement in G-protein-dependent lymphocyte recruitment into the central nervous system during experimental autoimmune encephalomyelitis. Eur. J. Immunol. 32:2133-2144. doi:10.1002/1521-4141(200208)32:8〈2133::AID- IMMU2133〉3.0.CO;2-W (Pubitemid 34965876)
2. Appleton, B.A., P. Wu, and C. Wiesmann. 2006. The crystal structure of murine coronin-1: a regulator of actin cytoskeletal dynamics in lymphocytes. Structure. 14:87-96. doi:10.1016/j.str.2005.09.013
3. Boulanger, L.M. 2009. Immune proteins in brain development and synaptic plasticity. Neuron. 64:93-109. doi:10.1016/j.neuron.2009.09.001
4. Burkhardt, J.K., E. Carrizosa, and M.H. Shaffer. 2008. The actin cytoskeleton in T cell activation. Annu. Rev. Immunol. 26:233-259. doi:10.1146/annurev.immunol.26.021607.090347
5. Chae, T., Y.T. Kwon, R. Bronson, P. Dikkes, E. Li, and L.H. Tsai. 1997. Mice lacking p35, a neuronal specific activator of Cdk5, display cortical lamination defects, seizures, and adult lethality. Neuron. 18:29-42. doi:10.1016/S0896-6273(01)80044-1
6. Chen, F., and G.P. Studzinski. 2001. Expression of the neuronal cyclin-dependent kinase 5 activator p35Nck5a in human monocytic cells is associated with differentiation. Blood. 97:3763-3767. doi:10.1182/blood.V97.12. 3763
7. Clemen, C.S., V. Rybakin, and L. Eichinger. 2008. The coronin family of proteins. Subcell. Biochem. 48:1-5. doi:10.1007/978-0-387-09595-0-1
8. Cohen, P. 2002. Protein kinases-the major drug targets of the twenty-first century? Nat. Rev. Drug Discov. 1:309-315. doi:10.1038/nrd773 (Pubitemid 37361447)
9. Coussens, L.M., and Z. Werb. 2002. Inflammation and cancer. Nature. 420:860-867. doi:10.1038/nature01322
10. Cruz, J.C., and L.H. Tsai. 2004. Cdk5 deregulation in the pathogenesis of Alzheimer's disease. Trends Mol. Med. 10:452-458. doi:10.1016/j.molmed.2004.07. 001
11. Cua, D.J., J. Sherlock, Y. Chen, C.A. Murphy, B. Joyce, B. Seymour, L. Lucian, W. To, S. Kwan, T. Churakova, et al. 2003. Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature. 421:744-748. doi:10.1038/nature01355
12. de Hostos, E.L., B. Bradtke, F. Lottspeich, R. Guggenheim, and G. Gerisch. 1991. Coronin, an actin binding protein of Dictyostelium discoideum localized to cell surface projections, has sequence similarities to G protein beta subunits. EMBO J. 10:4097-4104.
13. Dhavan, R., and L.H. Tsai. 2001. A decade of CDK5. Nat. Rev. Mol. Cell Biol. 2:749-759. doi:10.1038/35096019
14. Ferrari, G., H. Langen, M. Naito, and J. Pieters. 1999. A coat protein on phagosomes involved in the intracellular survival of mycobacteria. Cell. 97:435-447. doi:10.1016/S0092-8674(00)80754-0
15. Föger, N., L. Rangell, D.M. Danilenko, and A.C. Chan. 2006. Requirement for coronin 1 in T lymphocyte trafficking and cellular homeostasis. Science. 313:839-842. doi:10.1126/science.1130563
16. Fu, A.K., W.Y. Fu, A.K. Ng, W.W. Chien, Y.P. Ng, J.H. Wang, and N.Y. Ip. 2004. Cyclin-dependent kinase 5 phosphorylates signal transducer and activator of transcription 3 and regulates its transcriptional activity. Proc. Natl. Acad. Sci. USA. 101:6728-6733. doi:10.1073/pnas.0307606100
17. Gandhi, M., and B.L. Goode. 2008. Coronin: the double-edged sword of actin dynamics. Subcell. Biochem. 48:72-87. doi:10.1007/978-0-387-09595-0-7
18. Gatfield, J., I. Albrecht, B. Zanolari, M.O. Steinmetz, and J. Pieters. 2005. Association of the leukocyte plasma membrane with the actin cytoskeleton through coiled coil-mediated trimeric coronin 1 molecules. Mol. Biol. Cell. 16:2786-2798. doi:10.1091/mbc.E05-01-0042
19. Gong, X., X. Tang, M. Wiedmann, X. Wang, J. Peng, D. Zheng, L.A. Blair, J. Marshall, and Z. Mao. 2003. Cdk5-mediated inhibition of the protective effects of transcription factor MEF2 in neurotoxicity-induced apoptosis. Neuron. 38:33-46. doi:10.1016/S0896-6273(03)00191-0
20. Han, M.H., S.I. Hwang, D.B. Roy, D.H. Lundgren, J.V. Price, S.S. Ousman, G.H. Fernald, B. Gerlitz, W.H. Robinson, S.E. Baranzini, et al. 2008. Proteomic analysis of active multiple sclerosis lesions reveals therapeutic targets. Nature. 451:1076-1081. doi:10.1038/nature06559
21. Haraldsson, M.K., C.A. Louis-Dit-Sully, B.R. Lawson, G. Sternik, M.L. Santiago-Raber, N.R. Gascoigne, A.N. Theofilopoulos, and D.H. Kono. 2008. The lupus-related Lmb3 locus contains a disease-suppressing Coronin-1A gene mutation. Immunity. 28:40-51. doi:10.1016/j.immuni.2007.11.023
22. Huang, D., G. Patrick, J. Moffat, L.H. Tsai, and B. Andrews. 1999. Mammalian Cdk5 is a functional homologue of the budding yeast Pho85 cyclin-dependent protein kinase. Proc. Natl. Acad. Sci. USA. 96:14445-14450. doi:10.1073/pnas.96.25.14445
23. Karpus, W.J., and R.M. Ransohoff. 1998. Chemokine regulation of experimental autoimmune encephalomyelitis: temporal and spatial expression patterns govern disease pathogenesis. J. Immunol. 161:2667-2671.
24. Kim, Y., J.Y. Sung, I. Ceglia, K.W. Lee, J.H. Ahn, J.M. Halford, A.M. Kim, S.P. Kwak, J.B. Park, S. Ho Ryu, et al. 2006. Phosphorylation of WAVE1 regulates actin polymerization and dendritic spine morphology. Nature. 442:814-817. doi:10.1038/nature04976
25. Kitazawa, M., S. Oddo, T.R. Yamasaki, K.N. Green, and F.M. LaFerla. 2005. Lipopolysaccharide-induced inflammation exacerbates tau pathology by a cyclin-dependent kinase 5-mediated pathway in a transgenic model of Alzheimer's disease. J. Neurosci. 25:8843-8853. doi:10.1523/JNEUROSCI.2868-05.2005
26. Kroenke, M.A., T.J. Carlson, A.V. Andjelkovic, and B.M. Segal. 2008. IL-12- and IL-23-modulated T cells induce distinct types of EAE based on histology, CNS chemokine profile, and response to cytokine inhibition. J. Exp. Med. 205:1535-1541. doi:10.1084/jem.20080159
27. Kurosaki, T., and M. Hikida. 2009. Tyrosine kinases and their substrates in B lymphocytes. Immunol. Rev. 228:132-148. doi:10.1111/j.1600-065X.2008.00748. x
28. Lin, H., M.C. Chen, C.Y. Chiu, Y.M. Song, and S.Y. Lin. 2007. Cdk5 regulates STAT3 activation and cell proliferation in medullary thyroid carcinoma cells. J. Biol. Chem. 282:2776-2784. doi:10.1074/jbc.M607234200
29. Lu, S.X., O. Alpdogan, J. Lin, R. Balderas, R. Campos-Gonzalez, X. Wang, G.J. Gao, D. Suh, C. King, M. Chow, et al. 2008. STAT-3 and ERK 1/2 phosphorylation are critical for T-cell alloactivation and graft-versus-host disease. Blood. 112:5254-5258. doi:10.1182/blood-2008-03-147322
30. Lundmark, F., K. Duvefelt, E. Iacobaeus, I. Kockum, E. Wallström, M. Khademi, A. Oturai, L.P. Ryder, J. Saarela, H.F. Harbo, et al. 2007. Variation in interleukin 7 receptor alpha chain (IL7R) influences risk of multiple sclerosis. Nat. Genet. 39:1108-1113. doi:10.1038/ng2106
31. Mapelli, M., L. Massimiliano, C. Crovace, M.A. Seeliger, L.H. Tsai, L. Meijer, and A. Musacchio. 2005. Mechanism of CDK5/p25 binding by CDK inhibitors. J. Med. Chem. 48:671-679. doi:10.1021/jm049323m
32. Matthews, S.A., and D.A. Cantrell. 2006. The role of serine/threonine kinases in T-cell activation. Curr. Opin. Immunol. 18:314-320. doi:10.1016/j.coi.2006.03.006
33. Mi, S., B. Hu, K. Hahm, Y. Luo, E.S. Kam Hui, Q. Yuan, W.M. Wong, L. Wang, H. Su, T.H. Chu, et al. 2007. LINGO-1 antagonist promotes spinal cord remyelination and axonal integrity in MOG-induced experimental autoimmune encephalomyelitis. Nat. Med. 13:1228-1233. doi:10.1038/nm1664
34. Miyamoto, Y., J. Yamauchi, and A. Tanoue. 2008. Cdk5 phosphorylation of WAVE2 regulates oligodendrocyte precursor cell migration through nonreceptor tyrosine kinase Fyn. J. Neurosci. 28:8326-8337. doi:10.1523/JNEUROSCI.1482-08. 2008
35. Mueller, P., J. Massner, R. Jayachandran, B. Combaluzier, I. Albrecht, J. Gatfield, C. Blum, R. Ceredig, H.R. Rodewald, A.G. Rolink, and J. Pieters. 2008. Regulation of T cell survival through coronin-1-mediated generation of inositol-1,4,5-trisphosphate and calcium mobilization after T cell receptor triggering. Nat. Immunol. 9:424-431. doi:10.1038/ni1570
36. Nikolic, M., M.M. Chou, W. Lu, B.J. Mayer, and L.H. Tsai. 1998. The p35/Cdk5 kinase is a neuron-specific Rac effector that inhibits Pak1 activity. Nature. 395:194-198. doi:10.1038/26034
37. Noseworthy, J.H., C. Lucchinetti, M. Rodriguez, and B.G. Weinshenker. 2000. Multiple sclerosis. N. Engl. J. Med. 343:938-952. doi:10.1056/ NEJM200009283431307
38. Ohshima, T., J.M. Ward, C.G. Huh, G. Longenecker, Veeranna, H.C. Pant, R.O. Brady, L.J. Martin, and A.B. Kulkarni. 1996. Targeted disruption of the cyclin-dependent kinase 5 gene results in abnormal corticogenesis, neuronal pathology and perinatal death. Proc. Natl. Acad. Sci. USA. 93:11173-11178. doi:10.1073/pnas.93.20.11173
39. Pareek, T.K., J. Keller, S. Kesavapany, H.C. Pant, M.J. Iadarola, R.O. Brady, and A.B. Kulkarni. 2006. Cyclin-dependent kinase 5 activity regulates pain signaling. Proc. Natl. Acad. Sci. USA. 103:791-796. doi:10.1073/pnas. 0510405103
40. Pareek, T.K., J. Keller, S. Kesavapany, N. Agarwal, R. Kuner, H.C. Pant, M.J. Iadarola, R.O. Brady, and A.B. Kulkarni. 2007. Cyclin-dependent kinase 5 modulates nociceptive signaling through direct phosphorylation of transient receptor potential vanilloid 1. Proc. Natl. Acad. Sci. USA. 104:660-665. doi:10.1073/pnas.0609916104
41. Pawson, T., and J.D. Scott. 1997. Signaling through scaffold, anchoring, and adaptor proteins. Science. 278:2075-2080. doi:10.1126/science.278.5346.2075 (Pubitemid 28028310)
42. Pearce, J.M. 2005. Historical descriptions of multiple sclerosis. Eur. Neurol. 54:49-53. doi:10.1159/000087387
43. Prince, A.L., C.C. Yin, M.E. Enos, M. Felices, and L.J. Berg. 2009. The Tec kinases Itk and Rlk regulate conventional versus innate T-cell development. Immunol. Rev. 228:115-131. doi:10.1111/j.1600-065X.2008.00746.x
44. Proudfoot, A.E., A.L. de Souza, and V. Muzio. 2008. The use of chemokine antagonists in EAE models. J. Neuroimmunol. 198:27-30. doi:10.1016/j.jneuroim. 2008.04.007
45. Rashid, T., M. Banerjee, and M. Nikolic. 2001. Phosphorylation of Pak1 by the p35/Cdk5 kinase affects neuronal morphology. J. Biol. Chem. 276:49043-49052. doi:10.1074/jbc.M105599200
46. Rosales, J.L., and K.Y. Lee. 2006. Extraneuronal roles of cyclin-dependent kinase 5. Bioessays. 28:1023-1034. doi:10.1002/bies.20473
47. Salmond, R.J., A. Filby, I. Qureshi, S. Caserta, and R. Zamoyska. 2009. T-cell receptor proximal signaling via the Src-family kinases, Lck and Fyn, influences T-cell activation, differentiation, and tolerance. Immunol. Rev. 228:9-22. doi:10.1111/j.1600-065X.2008.00745.x
48. Schneider, A., G.W. Araújo, K. Trajkovic, M.M. Herrmann, D. Merkler, E.M. Mandelkow, R. Weissert, and M. Simons. 2004. Hyperphosphorylation and aggregation of tau in experimental autoimmune encephalomyelitis. J. Biol. Chem. 279:55833-55839. doi:10.1074/jbc.M409954200
49. Shelton, S.B., and G.V. Johnson. 2004. Cyclin-dependent kinase-5 in neurodegeneration. J. Neurochem. 88:1313-1326. doi:10.1111/j.1471-4159.2003. 02328.x
50. Shiow, L.R., D.W. Roadcap, K. Paris, S.R. Watson, I.L. Grigorova, T. Lebet, J. An, Y. Xu, C.N. Jenne, N. Föger, et al. 2008. The actin regulator coronin 1A is mutant in a thymic egress-deficient mouse strain and in a patient with severe combined immunodeficiency. Nat. Immunol. 9:1307-1315. doi:10.1038/ni.1662
51. Shiow, L.R., K. Paris, M.C. Akana, J.G. Cyster, R.U. Sorensen, and J.M. Puck. 2009. Severe combined immunodeficiency (SCID) and attention deficit hyperactivity disorder (ADHD) associated with a Coronin-1A mutation and a chromosome 16p11.2 deletion. Clin. Immunol. 131:24-30. doi:10.1016/j.clim.2008. 11.002
52. Strock, C.J., J.I. Park, E.K. Nakakura, G.S. Bova, J.T. Isaacs, D.W. Ball, and B.D. Nelkin. 2006. Cyclin-dependent kinase 5 activity controls cell motility and metastatic potential of prostate cancer cells. Cancer Res. 66:7509-7515. doi:10.1158/0008-5472.CAN-05-3048
53. Studzinski, G.P., and J.S. Harrison. 2003. The neuronal cyclin-dependent kinase 5 activator p35Nck5a and Cdk5 activity in monocytic cells. Leuk. Lymphoma. 44:235-240. doi:10.1080/1042819021000030009
54. Thome, M., and O. Acuto. 1995. Molecular mechanism of T-cell activation: role of protein tyrosine kinases in antigen receptor-mediated signal transduction. Res. Immunol. 146:291-307. doi:10.1016/0923-2494(96)80263-X
55. Upadhyay, A.K., A.K. Ajay, S. Singh, and M.K. Bhat. 2008. Cell cycle regulatory protein 5 (Cdk5) is a novel downstream target of ERK in carboplatin induced death of breast cancer cells. Curr. Cancer Drug Targets. 8:741-752. doi:10.2174/156800908786733405
56. Wilker, P.R., M. Kohyama, M.M. Sandau, J.C. Albring, O. Nakagawa, J.J. Schwarz, and K.M. Murphy. 2008. Transcription factor Mef2c is required for B cell proliferation and survival after antigen receptor stimulation. Nat. Immunol. 9:603-612. doi:10.1038/ni.1609
57. Wyss-Coray, T., and L. Mucke. 2002. Inflammation in neurodegenerative disease - a double-edged sword. Neuron. 35:419-432. doi:10.1016/S0896-6273(02) 00794-8
58. Xie, Z., K. Sanada, B.A. Samuels, H. Shih, and L.H. Tsai. 2003. Serine 732 phosphorylation of FAK by Cdk5 is important for microtubule organization, nuclear movement, and neuronal migration. Cell. 114:469-482. doi:10.1016/S0092-8674(03)00605-6
59. Yaffe, M.B., M. Schutkowski, M. Shen, X.Z. Zhou, P.T. Stukenberg, J.U. Rahfeld, J. Xu, J. Kuang, M.W. Kirschner, G. Fischer, et al. 1997. Sequence-specific and phosphorylation-dependent proline isomerization: a potential mitotic regulatory mechanism. Science. 278:1957-1960. doi:10.1126/science.278.5345.1957
60. Yang, H.S., and P.W. Hinds. 2003. Increased ezrin expression and activation by CDK5 coincident with acquisition of the senescent phenotype. Mol. Cell. 11:1163-1176. doi:10.1016/S1097-2765(03)00135-7